Cl.[Cl:2][C:3]1[CH:4]=[C:5]([C:22]([NH2:24])=[O:23])[C:6](=[NH:21])[N:7]([CH2:9][C:10]2[CH:15]=[C:14]([Cl:16])[CH:13]=[CH:12][C:11]=2[S:17]([CH3:20])(=[O:19])=[O:18])[CH:8]=1>[OH-].[Na+]>[Cl:2][C:3]1[CH:4]=[C:5]([C:22]([NH2:24])=[O:23])[C:6](=[NH:21])[N:7]([CH2:9][C:10]2[CH:15]=[C:14]([Cl:16])[CH:13]=[CH:12][C:11]=2[S:17]([CH3:20])(=[O:19])=[O:18])[CH:8]=15-Chloro-1-[5-chloro-2-(methylsulfonyl)benzyl]-2-imino-1,2-dihydropyridine-3-carboxamide hydrochloride obtained in Example 1 (0.30 g) was dissolved in 1N aqueous sodium hydroxide solution, and the solution was extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over magnesium sulfate, and filtered. The solvent was evaporated under reduced pressure. The precipitated crystals were collected by filtration to give the title compound (0.23 g).